Home / Conferences / Medicines for Europe 16th Legal Affairs Conference 2021
Medicines for Europe 16th Legal Affairs Conference 2021 Posted 21/02/2020
16th Legal Affairs Conference 2021
September 2021
The Tower Hotel, London
UK
The next Medicines for Europe Legal Affairs Conference will be held in London, UK. The 16th edition of this event will provide an unmissable opportunity for participants to discuss all the main legal and IP issues in the pharmaceutical sector with leading industry executives and experts, counsel and European institution officials. All the opportunities and challenges for the generic, biosimilar and value-added medicines sectors within Europe and worldwide will be addressed.
The conference will include a: Take up the opportunity to attend this event and join in shaping discussions at the interactive roundtables on topics that will include competition policies, Brexit, second medical use patents, artificial intelligence and IP, the 505(b)(2) system in the US, and more… For more details, visit: https://www.medicinesforeurope.com/lac21/
• high level General Counsel discussion
• debate around the pharma incentives review
• discussion around the latest developments on the Supplementary Protection Certificate (SPC) Regulation
• focus on the challenges and opportunities on biosimilars in Europe and the US
• reflection on patent quality & the European patent system
• review of the existing patent linkages in the EU Member States
Comments (0)
Generics News Research General
- The role of authorized generics in Improving a...Generics/Research | Posted 05/03/2021
- Opportunities for generics with Korean patent e...Generics/General | Posted 05/03/2021
- Approving generics of polymer-based parenteral...Generics/Research | Posted 26/02/2021
- AIFA updates the Transparency Lists for genericsGenerics/General | Posted 26/02/2021
Biosimilars News Research General
- Biosimilar patent litigation trends in the USBiosimilars/General | Posted 05/03/2021
- Biosimilars approved in the USBiosimilars/General | Posted 14/08/2015
- Different approaches to the interchangeability...Biosimilars/Research | Posted 05/03/2021
- Efficacy and safety of interferon beta-1a (Reci...Biosimilars/Research | Posted 05/03/2021